- Home
- ATCH vs TTNP Comparison
ATCH vs TTNP Comparison
Compare ATCH & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATCH
- TTNP
- Stock Information
- Founded
- ATCH 2022
- TTNP 1991
- Country
- ATCH United States
- TTNP United States
- Employees
- ATCH N/A
- TTNP N/A
- Industry
- ATCH
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ATCH
- TTNP Health Care
- Exchange
- ATCH Nasdaq
- TTNP Nasdaq
- Market Cap
- ATCH 2.5M
- TTNP 3.0M
- IPO Year
- ATCH N/A
- TTNP 1996
- Fundamental
- Price
- ATCH $6.50
- TTNP $3.79
- Analyst Decision
- ATCH
- TTNP
- Analyst Count
- ATCH 0
- TTNP 0
- Target Price
- ATCH N/A
- TTNP N/A
- AVG Volume (30 Days)
- ATCH 85.9K
- TTNP 41.9K
- Earning Date
- ATCH 02-20-2025
- TTNP 01-03-2025
- Dividend Yield
- ATCH N/A
- TTNP N/A
- EPS Growth
- ATCH N/A
- TTNP N/A
- EPS
- ATCH 2.67
- TTNP N/A
- Revenue
- ATCH N/A
- TTNP N/A
- Revenue This Year
- ATCH N/A
- TTNP N/A
- Revenue Next Year
- ATCH N/A
- TTNP N/A
- P/E Ratio
- ATCH $2.43
- TTNP N/A
- Revenue Growth
- ATCH N/A
- TTNP N/A
- 52 Week Low
- ATCH $0.12
- TTNP $3.03
- 52 Week High
- ATCH $15.27
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- ATCH 33.56
- TTNP 48.54
- Support Level
- ATCH $6.48
- TTNP $3.14
- Resistance Level
- ATCH $9.87
- TTNP $3.38
- Average True Range (ATR)
- ATCH 1.81
- TTNP 0.22
- MACD
- ATCH -0.30
- TTNP 0.02
- Stochastic Oscillator
- ATCH 3.84
- TTNP 52.24
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.